Clinical Trial Update: Effects of MTS-r on Speech Production in Non-fluent Aphasia Post-ischemic Stroke Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating MTS-r to improve speech in non-fluent aphasia after ischemic stroke; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphasia
• Broca Aphasia

Drugs mentioned

• MTS-r

Snippet

Sponsor: Fundación Cardiovascular de Colombia | Conditions: Aphasia, Broca | Phase 3 | Status: UNKNOWN